Division of Health Economics

Prof. Dr. Michael Schlander

© dkfz.de

The Division of Health Economics at the German Cancer Research Center (DKFZ) was established in 2017.
The aim of the Division will be to contribute to improving our understanding of the costs and cost effectiveness of cancer care – spanning the whole continuum from prevention and early detection / screening to diagnosis and treatment. To this end, the Division will establish relevant interdisciplinary collaborations both within the DKFZ and its networks, as well as with other German and international scientific institutions.

The Division aims to become

  • the primary national point of reference for information on the cost of cancer and the cost-effectiveness of interventions designed to improve cancer-related outcomes;
  • an important contributor to the advancement of health economic evaluation methods (better) reflecting the social objectives of collectively financed health schemes.
At the 20th Annual European Congress of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) in Glasgow, Scotland, November 2017, the founding head of the Division, Professor Michael Schlander, was interviewed for BBC Scotland. Here are his answers to four topics he was asked about, i.e., The DKFZ published in February 2017 an interview with Professor Schlander, in which he summarized some of the salient points discussed before:
M. Schlander: Interview: Für mehr Klarheit [For more clarity] DKFZ Intern, (2017) 2 14-17.


Prof. Dr. Michael Schlander
Health Economics (C100)
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 581
69120 Heidelberg

Katrin Eike-Verfürth

k.eike-verfuerth (at) dkfz.de
Phone: +49 6221 42-1911
Fax: +49 6221 42-1919

to top